Pharmaceutical Stocks

Kodak Stock Goes Wild I think it's safe to say that Eastman Kodak Company (NYSE:KODK) wasn't really on anyone's radar before the last few days. Famous for being a more-than-century-old American photography company, and more recently for going bankrupt in 2011, Kodak has almost overnight become one of…

Moderna Stock Remains Volatile Shares of Moderna Inc (NASDAQ:MRNA) have shot up nearly 300% since February, when I first wrote about it. The company has had a rough road since then, and I'm here to reassess MRNA stock and explain how best to profit from what is among the…

Moderna Stock Shorts Could Actually Be Good When a stock gets hot and juicy, it draws the wolves, traders looking to make a buck by short-selling what they believe is a company riding the hype train. Sure, sometimes the wolves are right, predicting major collapses and reaping the…

Coronavirus Stocks Could Soar Due to COVID-19 Vaccine It seems simple: if you're able to cure a global pandemic, it would only make sense that you'd be rewarded financially (not to mention have literally millions of people thanking you for getting us out of the nightmare). As you'd…

Coronavirus-Driven Market Puts Emphasis on Pharma Stocks As you'd expect during a pandemic, those who make medicine are among the best situated to eke out a profit, even as most other stocks tumble. Considering that gold and bonds and other traditional safe-haven investments are falling at the moment,…

Psychedelic Stocks a Great Opportunity for Cannabis Investors Once-taboo psychedelic mushrooms have finally gone mainstream, with the recent initial public offerings (IPOs) of Mind Medicine Inc (OTCMKTS:MMEDF, NEO:MMED) and Champignon Brands (CNSX:SHRM). Both stocks officially began trading in the first week of March. Mind Medicine Inc, also known as MindMed,…

Moderna Stock Soaring Following News of Coronavirus Vaccine The stock market recently took a big hit after the coronavirus, a sickness that first spread from China, started popping up around the globe. Concerns about the potential for an epidemic have everyone paying attention—investors included—and that has slowed stock…